Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (NY: MSOS )

3.620 -0.270 (-6.94%)
Official Closing Price Updated: 6:30 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,896,688
Open 3.880
Bid (Size) 3.620 (4)
Ask (Size) 3.650 (23)
Prev. Close 3.890
Today's Range 3.600 - 3.880
52wk Range 3.420 - 11.37
Shares Outstanding 1,305,750
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-11.27%
-11.27%
1 Month
-12.35%
-12.35%
3 Month
-47.84%
-47.84%
6 Month
-48.65%
-48.65%
1 Year
-53.29%
-53.29%

More News

Read More
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Via Benzinga
Topics Cannabis
Exposures Cannabis
Here's Why Tilray Brands' CEO Is Optimistic Marijuana Legalization Will Happen Under the Trump Administration
Via The Motley Fool
Topics Cannabis Government
Exposures Cannabis Political
Turnaroud Tuesday: Did Canna Finally Bottom?
Via Talk Markets
Cannabis Reform 2024: The Year Of All Talk And No Action
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Via Benzinga
Topics Cannabis ETFs Government
Exposures Cannabis Political
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Matt Gaetz Is Trump's Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation
Via Benzinga
Topics Government
Exposures Political
Stocks Of The Day: 4-Pillar Power Plays You Can’t Miss - Today’s Biggest Movers
Via Talk Markets
Topics Economy
Exposures Interest Rates
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
The Good, The Bad, And The Ugly: A Recap Of Post-Vote Winners & Losers
Via Talk Markets
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Capital Markets: Bright 2025 Outlook Amid Regulatory Shifts
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
Via Benzinga
Topics Cannabis
Exposures Cannabis
AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
'The Biggest Opportunities For Investors Outside AI': Optimism Reigns At Benzinga Conference Amid Talks Of Cannabis Rescheduling, Tech Advances
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say
Via Benzinga
Topics Cannabis
Exposures Cannabis
Profit from the Green Wave: Top Cannabis Stocks to Watch
Via MarketBeat
Topics Cannabis
Exposures Cannabis
Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows
Via Benzinga
Topics Cannabis
Exposures Cannabis
Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate
Via Benzinga
Topics Cannabis
Exposures Cannabis
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.